4.6 Article

Physiology of the normal and dopamine-depleted basal ganglia: Insights into levodopa pharmacotherapy

Journal

MOVEMENT DISORDERS
Volume 23, Issue -, Pages S560-S569

Publisher

WILEY
DOI: 10.1002/mds.22020

Keywords

dopamine; Parkinson's disease; nucleus accumbens; long-term potentiation; tonic-phasic

Funding

  1. USPHS [MH57440, DA15408]
  2. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057440, R37MH057440] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015408] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Dopamine (DA) neurons exist in two activity states: either spontaneously firing or quiescent and nonfirming. When faced with a behavioral demand, the quiescent D neurons can be activated to facilitate normal motor out-put. Levodopa appears to increase DA Output by activating, these nonfiring neurons: as a consequence, DA release IS increased, but behavioral demand can now overwhelm the system, potentially leading to the inactivation and on/off phenomena. Levodopa administered in a pulsatile manner may also lead to the induction of synaptic plasticity within the DA systems. In the ventral mesolimbic system. this could lead to the loss of behavioral flexibility, impulsive behavior, and cognitive impairment. whereas in the dorsal nigrostriatal system, this may underlie Levodopa-induced dyskinesia. Continuous administration of Levodopa may circumvent this sensitization process. enabling a therapeutic response without limbic and motor side effects. (c) 2008 Movement Disorder Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia

Susan F. Sonnenschein, Kathryn M. Gill, Anthony A. Grace

NEUROPSYCHOPHARMACOLOGY (2019)

Review Neurosciences

Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia

Susan F. Sonnenschein, Anthony A. Grace

NEUROPHARMACOLOGY (2020)

Review Endocrinology & Metabolism

Adaptations in reward-related behaviors and mesolimbic dopamine function during motherhood and the postpartum period

Millie Rincon-Cortes, Anthony A. Grace

FRONTIERS IN NEUROENDOCRINOLOGY (2020)

Article Neurosciences

Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats

Xiyu Zhu, Anthony A. Grace

Summary: This study found that early environmental enrichment (EE) in prepubertal rats can prevent dopamine hyperresponsivity in the MAM model of schizophrenia, as measured by electrophysiological recordings and locomotor response to amphetamine. EE normalized excessive firing in the ventral hippocampus without affecting anxiety-like behaviors and basolateral amygdala firing, indicating its potential as a preventative approach for schizophrenia.

BIOLOGICAL PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

Felipe V. Gomes, Anthony A. Grace

Summary: Although currently available antipsychotic drugs can reduce psychotic symptoms in schizophrenia patients, they have numerous side effects and are not effective against negative and cognitive symptoms. Developing new drugs that target the excitatory/inhibitory balance in the brain may offer a more effective approach in treating schizophrenia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Psychiatry

Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia

Susan F. Sonnenschein, Anthony A. Grace

Summary: The study found that peripubertal administration of POM in MAM rats can prevent the emergence of vHPC pyramidal neuron hyperactivity and increased DA neuron population activity in adulthood, showing potential for preventing dopamine system dysfunction and psychosis development. However, POM did not show significant differences in SAL rats.

SCHIZOPHRENIA BULLETIN (2021)

Article Clinical Neurology

Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia

Jillian J. Weeks, Anthony A. Grace, Alan F. Sved

Summary: The study showed that both acute and chronic administration of nicotine improved deficits in schizophrenia-like behaviors and normalized neuronal activity in specific brain regions in the schizophrenia rodent model. These findings support the self-medication hypothesis for smoking in schizophrenia and suggest the potential of nicotinic modulation in future pharmacotherapies.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)

Article Clinical Neurology

The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion

Laszlo Peczely, Tamas Ollmann, Kristof Laszlo, Laszlo Lenard, Anthony A. Grace

Summary: Quinpirole dose dependently regulates VTA dopaminergic activity and influences motivation and motor behavior in rats at the level of the ventral pallidum.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Sex- and exposure age-dependent effects of adolescent stress on ventral tegmental area dopamine system and its afferent regulators

Xiyu Zhu, Anthony A. Grace

Summary: Adolescent stress is a risk factor for schizophrenia, and its effects on neurobiological activity and impairment vary depending on age and sex. Understanding these differences could provide insights into the underlying mechanisms of stress-related psychopathologies and guide targeted interventions.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Levetiracetam Attenuates Adolescent Stress-induced Behavioral and Electrophysiological Changes Associated With Schizophrenia in Adult Rats

Andreza M. Cavichioli, Thamyris Santos-Silva, Anthony A. Grace, Francisco S. Guimaraes, Felipe Gomes

Summary: This study suggests that levetiracetam can attenuate the adverse outcomes associated with schizophrenia caused by stress during adolescence, by reversing the behavioral changes, ventral hippocampus hyperactivity, and enhanced ventral tegmental area dopamine system activity.

SCHIZOPHRENIA BULLETIN (2023)

Article Clinical Neurology

Medial Prefrontal Cortex to Medial Septum Pathway Activation Improves Cognitive Flexibility in Rats

David M. Bortz, Catalina M. Feistritzer, Anthony A. Grace

Summary: This study suggests that the medial prefrontal cortex (mPFC) to medial septum (MS) pathway may be involved in regulating cognitive flexibility and dopamine neuron activity. Activation of the mPFC-MS pathway improves strategy switching, while inhibition produces different effects. The pathway bidirectionally regulates dopamine neuron activity. This study reveals a potential top-down circuit from the prefrontal cortex to the midbrain that can manipulate dopamine activity to promote cognitive flexibility.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets

Anthony A. Grace, Daniela L. Uliana

Summary: Therapeutic intervention for schizophrenia relies on blockade of dopamine D2 receptors to alleviate symptoms. However, an overactive hippocampus is the primary driver of dopamine system hyper-responsiveness. Antipsychotic drugs alleviate symptoms by causing depolarization block, but they also activate multiple synapses downstream from the site of pathology. A novel class of drugs targeting the hippocampal overdrive could be more effective and better tolerated.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemical Research Methods

Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk

Xiyu Zhu, Anthony A. Grace

Summary: This study presents a protocol for delivering environmental enrichment in discrete postnatal windows to prevent long-term dopamine neuron dysfunctions in a neurodevelopmental rat model of schizophrenia risk. It describes the generation of the schizophrenia model through prenatal treatment and the application of EE paradigms on male rats at different ages. Control groups in regular environment cages are also included for comparison.

STAR PROTOCOLS (2022)

No Data Available